Updates on DME and RVO: from the pathogenesis to the treatment
Explore the role of inflammation in disease development, the use of biomarkers and multimodal imaging for diagnosis, and their prognostic value in guiding treatment. Review clinical and real-world evidence on Dexamethasone implants, their safety, and long-term benefits, while also addressing the role of combination therapy in managing complex cases.
ESASO Scientific Director: Mario Romano
Course Scientific Coordinator: Giuseppe Querques, Riccardo Sacconi
Teaching language: English 
Next Course in 2027 
⭐⭐⭐⭐⭐ More than 1700 students
What you'll learn
✔️
Understand the role of inflammation in the pathogenesis of diabetic retinopathy and retinal vein occlusion (RVO).
✔️
Explore biomarkers of inflammation and vascular impairment in the diagnosis of diabetic macular edema (DME).
✔️
Evaluate the prognostic value of biomarkers to guide treatment choices.
✔️
Review evidence on Dexamethasone implant as a first-line treatment in DME and RVO.
✔️
Analyze safety data and real-world outcomes of DEX implant use.
✔️
Learn about the role and timing of combination therapy in clinical practice.
Skills you'll acquire
Pathogenesis analysis
Biomarker interpretation
Anti-VEGF therapy
Steroid therapy
FREE Course
Take me to the registration form
2 hours of course 
Downloadable resources 
eLOS account
Assistance of Event Manager 
ESASO Certificate of Attendance
Swiss-level organisation